A Diabetes RELIEF Initiative: Realizing the Potential of GLP-1 Receptor Agonists in Type 2 Diabetes: Partnering with Patients to Improve Glycemic and Cardiovascular Outcomes
Podcast 3: The role of GLP-1 receptor agonists in the care of patients with type 2 diabetes: A Nurse Practitioner’s Perspective
Post-Test/Evaluation

Questions marked with a * are required
20%
Contact Information
Credentials/Degree (MD, DO, RN, etc.)
Date of  Participation
Angela is an overweight 57-year-old woman with a history of cardiac arrest 2 years ago. She is newly diagnosed with diabetes. She initiates therapy on a GLP-1 receptor agonist. Which of the following are part of the rationale behind selecting this therapy?
Which of the following is not included in the 5As approach to establishing a patient/provider relationship when managing patients with type 2 diabetes?
Powered by QuestionPro